| Date Checked | 2026-02-19 22:15:28 |
|---|---|
| Graham Number | (PB)87.60 vs (PE)68.04 |
| Over / Under Value Percentage | 129.48% vs 151.81% |
| Dividend Yield | 2.45% |
| Dividend Date | 2026-03-10 |
| Symbol | JNJ |
| AssetType | Common Stock |
| Name | Johnson & Johnson |
| Description | Johnson & Johnson (JNJ) is a premier American multinational corporation founded in 1886, encompassing a wide-ranging portfolio in medical devices, pharmaceuticals, and consumer health products. Renowned for its commitment to innovation and quality, J&J plays a pivotal role in the global healthcare landscape, consistently ranking among the most valuable companies worldwide. As a cornerstone of the Dow Jones Industrial Average and boasting an esteemed AAA credit rating, the company exemplifies financial stability and operational proficiency. Positioned 36th on the Fortune 500 list, Johnson & Johnson is strategically focused on sustainable growth while continuing to deliver reliable health solutions to a diverse global market. |
| CIK | 200406 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NJ, UNITED STATES, 08933 |
| OfficialSite | https://www.jnj.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 495712469000 |
| EBITDA | 31922000000 |
| PERatio | 19.88 |
| PEGRatio | 2.81 |
| BookValue | 32.95 |
| DividendPerShare | 5.08 |
| EPS | 10.35 |
| RevenuePerShareTTM | 38.28 |
| ProfitMargin | 0.273 |
| OperatingMarginTTM | 0.302 |
| ReturnOnAssetsTTM | 0.0826 |
| ReturnOnEquityTTM | 0.336 |
| RevenueTTM | 92148998000 |
| GrossProfitTTM | 62988001000 |
| DilutedEPSTTM | 10.35 |
| QuarterlyEarningsGrowthYOY | 0.91 |
| QuarterlyRevenueGrowthYOY | 0.068 |
| AnalystTargetPrice | 211.38 |
| AnalystRatingStrongBuy | 4 |
| AnalystRatingBuy | 9 |
| AnalystRatingHold | 11 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 19.88 |
| ForwardPE | 18.05 |
| PriceToSalesRatioTTM | 5.38 |
| PriceToBookRatio | 6.31 |
| EVToRevenue | 5.72 |
| EVToEBITDA | 13.25 |
| Beta | 0.333 |
| 52WeekHigh | 215.19 |
| 52WeekLow | 137.89 |
| 50DayMovingAverage | 201.02 |
| 200DayMovingAverage | 174.77 |
| SharesOutstanding | 2409295000 |
| SharesFloat | 2405513000 |
| PercentInsiders | 0.049 |
| PercentInstitutions | 75.122 |
| ExDividendDate | 2026-02-24 |
| dateChecked | 2026-02-19 22:15:28 |
| fresh | 1 |